Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today provided key program updates, including new positive data from the ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta (CHD). Participants receiving ...

Ai Technology Group Inc. (OTCID:AIPG) (the “Company”) and AVM Biotechnology Inc. (“AVM”, the Washington State company that is the subject of the proposed merger) provide this joint press release. The ...

Investors poured into a room at #JPM26 to see how Revolution Medicines' CEO would dance around questions they knew he ...

Using a technique called ancestral sequence reconstruction (ASR), researchers at Wageningen University & Research in the ...

Nvidia and U.S. pharma giant Eli Lilly will spend $1 billion building a new joint research lab in the San Francisco Bay area ...

This floor price is at a premium to the stock's recent performance. On Monday, shares of Biocon settled 2 per cent lower at ...

Insmed's CEO said months ago that the commercial opportunity for the biotech's newly approved lung disease drug was "huge." ...

A team of researchers led by bioengineer Shaochen Chen will use 3D printing techniques to shape stem cells produced by local firm Allele Biotechnology ...

Mahoney brings deep market expertise to guide biotech and pharmaceutical occupiers BOSTON, MA / ACCESS Newswire / ...

J&J, having already announced several manufacturing investments in North Carolina, has announced another one: a new drug ...